Molecular Dynamics, Docking and QSAR Analysis of Naphthoquinone Derivatives as Topoisomerase 1 Inhibitors

Authors

  • Alpana Bastikar
  • Sharvari Kulkarni
  • Virupaksha Bastikar
  • Pallavi Patil
  • Shruti Baikerikar

Keywords:

topoisomerase 1, QSAR, molecular docking, naphthoquinones, pharmacophore

Abstract

The Topoisomerase 1 (Topo 1) enzyme has become an attractive target for the treatment of cancer. Using an integrative approach of molecular dynamics simulations, molecular docking and 2D and 3D quantitative structure–activity relationship (QSAR), analysis was carried on 90 naphthoquinone derivatives as Topo 1 inhibitors by using the human Topo 1-DNA cleavable complex. This model has the drug intercalated with its planar pharmacophore between +1 and -1 bp flanking cleavage site. The docking analysis reveals the importance of Asn 722 and Thr 718 amino acids as necessary active site interaction residues. The 2D and 3D QSAR models also gave satisfactory results with r2 as 0.6298 and 0.7868, respectively. The docking analysis and the biological activity are also correlated by the QSAR equations, thus validating the binding analysis. The results were used to build the structure activity relationship model required to improve the biological activity of naphthoquinone derivatives as Topo 1 inhibitors by including their pharmacophoric attributes to design and develop novel improved analogs.

 

Downloads

Published

2013-09-30

Issue

Vol. 2 No. 2 (2013)

Section

Research/Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.